GGrantIndex
Sort

141,003 grants matching cytokine

Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer

$987,911
Dashtimoghadam Erfan · Symphony Biosciences, Inc. · R44 · FY2025 · CA

Therapeutic Strategy to slow progression of calcific aortic valve stenosis

$987,837
Jordan D Miller · Mayo Clinic Rochester · UH2 · FY2013 · TR

Modulating mucosal DCs and T cells to limit SIV spread

$987,500
Melissa J Robbiani · Population Council · R37 · FY2009 · AI

Programming T Cell Fates for Therapeutic Use

$987,437
Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis

$987,225
Gary Fanger · Rise Therapeutics, Llc · R44 · FY2024 · AG

Control of Autoimmunity by Regulatory T Cells

$987,209
Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)

$987,185
Vikas R. Dharnidharka · Washington University · U01 · FY2023 · CA

Safety and Tolerability Studies for an Anti-Fibrin P2 Monoclonal Antibody for the Treatment of Alzheimer's Disease

$987,080
Jeffrey Stavenhagen · Therini Bio, Inc. · U01 · FY2021 · AG

Mesothelin-targeted immunotoxins in Pancreatic Cancer

$986,847
Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Mucosal Immunopathogenesis of Franscisella Tularensis

$986,732
Albany Medical College · P01 · FY2003 · AI

Gene Expression Profiling/Chronic Lymphocytic Leukemia

$986,494
Adrian U Wiestner · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL

Systemic regulation of metastasis

$986,490
David Charles Lyden · Weill Medical Coll Of Cornell Univ · R35 · FY2019 · CA

rhMFG-E8 as an Effective Adjuvant Therapy for Hemorrhagic Shock

$986,433
Max Brenner · Therasource, Llc · R44 · FY2021 · HL

Diet, Activity, and Lifestyle as a Risk Factor for Colorectal Cancer

$986,392
Martha Or Marty L Slattery · University Of Utah · R01 · FY2012 · CA

Development and Preclinical Applications of Pancreatic Adenocarcinoma Models

$986,350
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer's disease.

$986,184
Srikant Rangaraju · Yale University · R01 · FY2024 · AG

Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans

$986,138
Matthew S Freiberg · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · HL

Virus-Host Interactions: Induction and Evasion of Host Innate Immunity

$985,972
Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

RP3: Targeting ATG gene-dependent immunity for novel anti-infective therapeutics

$985,910
Herbert W Virgin · Ut Southwestern Medical Center · U19 · FY2019 · AI

Molecular mechanism of TNF signaling and apoptosis

$985,827
Zheng-Gang Liu · Clinical Sciences · Z01 · FY2007 · CA

KL4 Surfactant to Mitigate Radiation-Induced Lung Injury

$985,783
Robert Segal · Windtree Therapeutics, Inc. · R44 · FY2016 · AI

Modeling the effects of chronic marijuana use on neuroinflammation and HIV-related neuronal injury

$985,639
Christina S Meade · Duke University · R01 · FY2022 · DA

Factors Contributing to Oral Health Disparities in Appalachia

$985,515
Mary L Marazita · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · DE

Role Of Monocytes In Immunopathology

$985,363
Larry M Wahl · Dental & Craniofacial Research · Z01 · FY2007 · DE

Systems Biology Approach to Identifying Biomarkers for Alcoholic Liver Disease

$985,241
Ali Keshavarzian · Rush University Medical Center · RC2 · FY2010 · AA